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Background
The non-invasive assessment of the haemodynamic sig-
nificance of coronary artery disease is still challenging.
Cardiac MR perfusion imaging during the first pass after
i.v. administration of an extracellular contrast agents is
limited by the spatial and temporal resolution achievable
as well as by the artifacts seen in ultrafast MR-imaging.
Moreover the patient must be stressed while being inside
the magnet. Two injections of contrast are required, and a
time consuming data analysis is necessary.
The use of molecular MR-imaging by means of a target
specific contrast agent with perfusion dependent binding
to myocardium may enable prolonged visualization of
perfusion defects and thus may help to overcome limita-
tions of currently used first pass extracellular MRI. EP-
3600, a peptide-gadolinium hybrid, is a new Gd-contain-
ing molecular contrast agent which binds reversibly to
myocardial collagen. It consists of a 15 amino acid pep-
tide that is functionalized with three Gd-DOTA type
chelates on the N-terminus. In contrast to the compound
EP-3533 recently reported [1,2], EP-3600 uses the DOTA
chelator.
The aim of this study was to investigate the potential of
EP-3600 for the assessment of myocardial perfusion
defects in a swine model of coronary artery stenosis.
Methods
A significant coronary artery stenosis was modeled in 8
domestic swine using an undersized MR-compatible bal-
loon positioned in the LAD as verified by X-ray angiogra-
phy. Two animals died prior to contrast injection due to
arrythmias. In 5 swine, high spatial resolution T1-
weighted gradient echo imaging was performed prior, 5,
20, 40 and 60 minutes after i.v. administration of 12.3
μmol/kg EP-3600. Imaging parameter included a satura-
tion-preparation prepulse (103 ms for each slice), cardiac
triggering, TR = 4.6 ms, TE = 1.4 ms, flip angle = 12°, field-
of-view of 270 × 270 mm2, matrix of 256 × 256 with an
in-plane reconstructed voxel size of 1.05 × 1.05 mm2,
SENSE-factor 2.1, total imaging time for five 10 mm thick
slices 21 seconds at a heart rate of 80 beats/minutes allow-
ing for breath-hold imaging. Contrast was administered
during stress induced by an infusion of 250 μmol/kg/min
adenosine. One further swine served as a control and
received 0.05 mmol of standard Gd-DTPA. Yb-DTPA was
administered simultaneously in 5 pigs for comparison of
myocardium/plasma ratios.
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Images were subjectively assessed by two investigators
(good contrast, and signal-to-noise (SNR) and contrast-
to-noise ratio (CNR) over time were calculated.
Results
Normal myocardium showed a significant SNR increase
during the entire examination time. In all animals which
received EP-3600 (n = 5), the perfusion defect in the LAD
territory could be visualized with a high CNR for at least
20 minutes post contrast injection (Figure 1). A significant
higher myocardium/plasma ratio was found for EP3600
compared to the control agent Yb-DTPA (0.88 ± 0.26 vs
0.22 ± 0.08 respectively, p < 0.01). In the control swine
which received standard Gd-DTPA no perfusion defect
was visible at 5 minutes post injection or at later time
points.
Conclusion
EP-3600 is a new molecular MR-imaging contrast agent
which binds to the myocardium and enables prolonged,
high contrast and high spatial resolution visualization of
myocardial perfusion defects.
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Molecular MR-imaging of myocardial perfusion defect using EP-3600 and T1-weighted high spatial resolution gradient-echo imagingFigure 1
Molecular MR-imaging of myocardial perfusion defect using EP-3600 and T1-weighted high spatial resolution gradient-echo 
imaging. The perfusion defect in the LAD territory is clearly seen (arrows). In this swine, the defect is readily visible up to 60 
minutes after administration of EP-3600. Initial results of molecular MR-imaging of myocardial perfusion using a collagen-spe-
cific contrast agent are presented. This new agent enables prolonged, high contrast and high spatial resolution visualization of 
myocardial perfusion defects in a swine model of coroanry stenosis.Page 2 of 2
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